Literature DB >> 18750532

General and family practice: changing role of digoxin in chronic heart failure.

R L Reed.   

Abstract

The Scientific Board of the California Medical Association presents the following inventory of items of progress in general and family practice. Each item, in the judgment of a panel of knowledgeable physicians, has recently become reasonably firmly established, both as to scientific fact and important clinical significance. The items are presented in simple epitome and an authoritative reference, both to the item itself and to the subject as a whole, is generally given for those who may be unfamiliar with a particular item. The purpose is to assist busy practitioners, students, research workers, or scholars to stay abreast of these items of progress in general and family practice that have recently achieved a substantial degree of authoritative acceptance, whether in their own field of special interest or another.The items of progress listed below were selected by the Advisory Panel to the Section on General and Family Practice of the California Medical Association and the summaries were prepared under its direction.

Entities:  

Year:  1989        PMID: 18750532      PMCID: PMC1026333     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  3 in total

1.  An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients.

Authors:  K J Carlson; D C Lee; A H Goroll; M Leahy; R A Johnson
Journal:  J Chronic Dis       Date:  1985

Review 2.  Digitalis. An update of clinical pharmacokinetics, therapeutic monitoring techniques and treatment recommendations.

Authors:  A D Mooradian
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

3.  Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm.

Authors:  M Gheorghiade; G A Beller
Journal:  Am J Cardiol       Date:  1983-05-01       Impact factor: 2.778

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.